Transforming growth factor-β1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27(Kip1) protein in cervical carcinoma

Gynecologic Oncology

Volumn 69, Issue 3, 1998, Pages 230-236

  Kim, Jin Woo ^a,b   Kim, Ho Shik ^c   Kim, In Kyung ^b,c   Kim, Mee Ran ^a   Cho, Eun Young ^a,b   Kim, Heung Kee ^a   Lee, Joon Mo ^a   Namkoong, Sung Eun ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DNA FRAGMENT; MESSENGER RNA; PROTEIN P27; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0032102238     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5003     Document Type: Article

References (39)

1. Assoian R K, Komoriya A, Meyers C A, Miller D M, Sporn M B. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J Biol Chem. 258:1983;7155-7160.
2. Sporn M B, Roberts A B. The Multifunctional Nature of Peptide Growth Factors. Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors. 1990;Springer-Verlag, New York. p. 3-15.
3. Moses H L, Tucker R F, Leof E B, Coffey R J, Halper J, Shipley G D. Type-β Transforming Growth Factor Is a Growth Stimulator and a Growth Inhibitor. Feramisco J, Ozanne B, Stiles C. Growth Factors and Transformation: Cancer Cells. 1985;59-64 Cold Spring Harbor Laboratory Press, New York.
4. Manning A M, Williams A C, Game S M, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene. 6:1991;1471-1476.
5. Braun L, Durst R, Mikumo R, Gruppuso P. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β1. Cancer Res. 50:1990;7324-7332.
6. Woodworth C D, Notario V, DiPaolo J A. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol. 64:1990;4767-4775.
7. Mulder K M, Levine A E, Hernandez X, McKnight M K, Brattain D E, Brattain M G. Modulation of c-myc by transforming growth factor-β in human colon carcinoma cells. Biochem Biophys Res Commun. 150:1988;711-716.
8. Yanagihara K, Tsumuraya M. Transforming growth factor beta induces apoptotic cell death in cultured gastric carcinoma cells. Cancer Res. 52:1992;4042-4045.
9. Briskin K B, Fady C, Mickel R A, Wang M, Lichtenstein A. Inhibition of head and neck squamous cell carcinoma cell lines by transforming growth factor-β Otolaryngol Head Neck Surg. 112:1995;728-734.
10. Coffey R J Jr, Bascom C C, Sipes N J, Graves-Deal R, Weissman B E, Moses H L. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor-β Mol Cell Biol. 8:1988;3088-3093.
11. Alvarez E, Northwood I C, Gonzalez F A, Latour D A, Seth A, Abate C, Curran T, Davis R J. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem. 266:1991;15277-15285.
12. Kato G J, Dang A C. Function of the c-myc oncoprotein. FASEB J. 6:1992;3065-3072.
13. Pietenpol J A, Holt J T, Stein R W, Moses H L. Transforming growth factor β-1 suppression ofc-myc. Proc Natl Acad Sci USA. 87:1990;3758-3762.
14. Munger K, Pietenpol J A, Pittelkow M R, Holt J T, Moses H L. Transforming growth factor β1 regulation ofc-myc. Cell Growth Differ. 3:1992;291-298.
15. 1. Mol Biol Cell. 5:1994;375-388.
16. Alexandrow M G, Moses H L. Transforming growth factor β and cell cycle regulation. Cancer Res. 55:1995;1452-1457.
17. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
18. Hunter T. Braking the cycle. Cell. 75:1993;839-841.
19. 1. Proc Natl Acad Sci USA. 90:1993;10315-10319.
20. Kip1. Genes Dev. 8:1994;9-22.
21. Toyoshima H, Hunter T. p27, Cell. 78:1994;67-74.
22. Kim J W, Cho Y H, Lyu M S, Lee C G, Jung J K, Kim S J, Namkoong S E. Establishment and characterization of a cell line (CUMC-3) derived from a human squamous carcinoma of the uterine cervix. Gynecol Oncol. 57:1995;47-60.
23. Kim J W, Lee C G, Cho Y H, Kim J H, Kim S J, Kim H K, Park T C, Song S K, Namkoong S E. CUMC-6, a new diploid human cell line derived from a squamous carcinoma of the uterine cervix. Gynecol Oncol. 62:1996;230-240.
24. Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
25. Wyllie A H, Kerr J FR, Currie A R. Cell death: The significance of apoptosis. Int Rev Cytol. 68:1980;251-306.
26. Pietenpol J A, Stein R W, Moran E, Yaciuk P, Schlegel R, Lyons R M, Pittelkow M R, Munger K, Howley P M, Moses H L. TGF-β1 inhibition ofc-myc. Cell. 61:1990;777-785.
27. Laiho M, DeCaprio J A, Ludlow J W, Livingston D M, Massagu J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell. 62:1990;175-185.
28. 1. Science. 260:1993;536-539.
29. Ewen M E, Sluss H K, Whitehouse L L, Livingston D M. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 74:1993;1009-1020.
30. Slingerland J M, Hengst L, Pan C-H, Alexander D, Stampfer M R, Reed S I. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol. 14:1994;3683-3694.
31. Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wesselbecher J, Draetta G, Eilers M. Differential modulation of cyclin gene expression by MYC. Proc Natl Acad Sci USA. 90:1993;3685-3689.
32. Daksis J I, Lu R Y, Facchini L M, Martin W W, Penn L JZ. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogne. 9:1994;3635-3645.
33. Satterwhite D J, Aakre M E, Gorska A E, Moses H L. Inhibition of cell growth by TGF-β1 is associated with inhibition of B-myb. Cell Growth Differ. 5:1994;789-799.
34. Fernandez-Pol J A, Talkad V D, Klos D J, Hamilton P D. Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor β in a human breast carcinoma cell line. Biochem Biophys Res Commun. 144:1987;1197-1205.
35. Chambard J C, Pouyssegur J. TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events. J Cell Physiol. 135:1987;101-107.
36. 1. Exp Cell Res. 171:1987;213-222.
37. Kip1. Cell. 78:1994;59-66.
38. Ewen M E, Sluss H K, Whitehouse L L, Livingstone D M. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 74:1993;1009-1120.
39. Grana X, Reddy E P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 11:1995;211-219.